Neoadjuvant therapy strategies for advanced gastric cancer: Current innovations and future challenges
Gastric cancer, which has a high incidence and poor prognosis, remains a therapeutic challenge. Recently, neoadjuvant therapy has attracted increasing attention due to high recurrence rate and low survival rate after resection in most patients with advanced stage. Clinical trials show that neoadjuva...
Main Authors: | Zhi Zhu, Ying-Bo Gong, Hui-Mian Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Chronic Diseases and Translational Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X20300359 |
Similar Items
-
Neoadjuvant systemic therapy for patients with gastric cancer: Current concepts and outcomes
by: Fatih Selcukbiricik, et al.
Published: (2016-01-01) -
Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy
by: Hong Yu, et al.
Published: (2022-09-01) -
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
by: Masanori Tokunaga, et al.
Published: (2023-11-01) -
Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01) -
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
by: Angelica Petrillo, et al.
Published: (2019-03-01)